13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2026. See the latest, Q2 2026 →
Reported value
$535.46B
−6.2% on the quarter before
Positions
1,869
165 new · 208 sold out
Top 10
25.6%
of the value
Est. gain
−$19.40B
on stocks held all quarter
Est. return
−4.0%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 36% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Astrazeneca Plc~$4.63BNew · 0.0% → 0.9%+23,751,085 shares
- BlackRock~$2.11BAdded · 0.3% → 0.7%+2,193,546 shares
- Diamondback Energy~$1.83BAdded · 0.1% → 0.5%+9,261,467 shares
- Meta~$1.67BAdded · 1.0% → 1.2%+2,915,166 shares
- Northrop Grumman~$1.48BAdded · 0.3% → 0.6%+2,170,005 shares
- KLA~$1.48BAdded · 0.1% → 0.4%+1,002,441 shares
- Microsoft~$1.42BAdded · 4.1% → 3.6%+3,832,724 shares
- Eaton~$1.38BAdded · 0.1% → 0.4%+3,870,604 shares
- Netflix~$1.38BAdded · 0.3% → 0.6%+14,346,362 shares
- Spotify~$1.17BAdded · 0.1% → 0.3%+2,420,870 shares
Largest sells
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$3.11BCut · 3.7% → 3.1%−12,271,790 shares
- Alphabet~$2.78BCut · 3.1% → 2.6%−9,665,827 shares
- Astrazeneca Plc~$2.10BSold out · 0.4% → 0.0%−22,828,246 shares
- Caterpillar Inc.~$1.94BCut · 0.4% → 0.1%−2,741,180 shares
- JPMorgan Chase~$1.93BCut · 0.6% → 0.2%−6,565,981 shares
- Morgan Stanley~$1.84BCut · 0.5% → 0.1%−11,194,880 shares
- AbbVie~$1.75BCut · 0.6% → 0.3%−8,028,867 shares
- UnitedHealth Group~$1.51BCut · 0.9% → 0.5%−5,597,135 shares
- ConocoPhillips~$1.40BCut · 0.4% → 0.3%−10,605,411 shares
- Accenture~$1.34BCut · 0.5% → 0.1%−6,741,493 shares
Holdings
As of Mar 31, 2026. Changes are in shares against Dec 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares −4.9% · price −6.5% | 4.4% | $23.34B | −$1.62B | ||||||||
| MicrosoftCOM · shares +7.8% · price −23.5% | 3.6% | $19.52B | −$5.55B | ||||||||
| AppleCOM · shares −16% · price −6.6% | 3.1% | $16.50B | −$1.18B | ||||||||
| BroadcomCOM · shares +4.9% · price −10.6% | 2.9% | $15.38B | −$1.73B | ||||||||
| AlphabetCAP STK CL A · shares −17% · price −8.1% | 2.6% | $13.69B | −$1.21B | ||||||||
| AmazonCOM · shares −5.8% · price −9.8% | 2.4% | $13.00B | −$1.41B | ||||||||
| Eli LillyCOM · shares +0.5% · price −14.4% | 2.3% | $12.35B | −$2.07B | ||||||||
| Merck & Co.COM · shares −2.5% · price +14.3% | 1.9% | $10.14B | +$1.27B | ||||||||
| MetaCL A · shares +33% · price −13.3% | 1.2% | $6.69B | −$771.8M | ||||||||
| MastercardCL A · shares −3.7% · price −12.5% | 1.2% | $6.50B | −$926.0M | ||||||||
| Wells FargoCOM · shares −9.1% · price −14.6% | 0.98% | $5.24B | −$894.8M | ||||||||
| Johnson & JohnsonCOM · shares −14% · price +18.1% | 0.92% | $4.91B | +$752.6M | ||||||||
| Astrazeneca PlcORD · shares New | 0.86% | $4.63B | — | ||||||||
| SempraCOM · shares −1.1% · price +10.1% | 0.84% | $4.48B | +$409.7M | ||||||||
| AlphabetCAP STK CL C · shares −9.7% · price −8.6% | 0.74% | $3.95B | −$371.2M | ||||||||
| ExxonMobilCOM · shares +7.4% · price +41.0% | 0.71% | $3.82B | +$1.03B | ||||||||
| Targa ResourcesCOM · shares −19% · price +35.9% | 0.70% | $3.77B | +$996.3M | ||||||||
| Honeywell TechnologiesCOM · shares +30% · price +15.9% | 0.70% | $3.76B | +$396.1M | ||||||||
| T-Mobile USCOM · shares +3.7% · price +3.4% | 0.67% | $3.61B | +$115.9M | ||||||||
| BlackRockCOM · shares +151% · price −10.1% | 0.65% | $3.51B | −$157.6M | ||||||||
| NetflixCOM · shares +68% · price +2.5% | 0.64% | $3.40B | +$50.3M | ||||||||
| TeslaCOM · shares −11% · price −17.3% | 0.64% | $3.40B | −$713.5M | ||||||||
| Northrop GrummanCOM · shares +77% · price +19.6% | 0.63% | $3.39B | +$313.8M | ||||||||
| WelltowerCOM · shares −9.1% · price +6.5% | 0.63% | $3.35B | +$205.1M | ||||||||
| Home Depot (The)COM · shares −10% · price −4.4% | 0.59% | $3.17B | −$146.6M | ||||||||
| Total · 1,869 positions | 100% | $535.46B | −$19.40B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 1,620 stocks held throughout, down $19.40B (−4.0%).
- Merck & Co.+$1.27B+14%
- ExxonMobil+$1.03B+41%
- Targa Resources+$996.3M+36%
- Johnson & Johnson+$752.6M+18%
- ConocoPhillips+$516.8M+41%
- Amazon−$1.41B−10%
- Nvidia−$1.62B−6%
- Broadcom−$1.73B−11%
- Eli Lilly−$2.07B−14%
- Microsoft−$5.55B−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |